CRT 2025 Meeting Unveils its Late-Breaking Scientific Programme
SOURCE: CRT 2025
PUBLISHED:

Cardiovascular Research Technologies has released three late-breaking clinical trial sessions and four clinical science sessions for its annual meeting in March 2025.

CRT 2025 will be held from the 8th to 11th March at the Washington Hilton Hotel in Washington, DC. View the full programme here.

 

Late-Breaking Clinical Trials: Coronary

Saturday 8th March, 14:00 – 15:15pm EST

  • Paclitaxel-Coated Balloon Versus Uncoated Balloon for Coronary In-Stent Restenosis – Two-Year Outcomes of the AGENT IDE Trial – Presented by Dr Jeffrey Moses
  • Real-World Usage of Prevail Paclitaxel-Coated Balloon Compared With Other Contemporary Drug-Coated Balloons – A Two-Year Analysis From the Swedish Coronary Angiography and Angioplasty Registry in Over 6,000 Patients – Presented by Dr Sacharias von Koch
  • Intravascular Lithotripsy or Mechanical Debulking for the Treatment of Complex Calcified Coronary Arteries: The Multicenter, Prospective ROLLING-STONE Trial – Presented by Dr Enrico Cerrato
  • The Impact of the RADPAD Protection Drape in Reducing Radiation Exposure in a Contemporary Cardiac Catheterization Laboratory | The ATTENUATE Trial – Presented by Dr Giorgio Medranda

 

Late-Breaking Clinical Trials: Structural

Monday 10th March, 11:45 – 12:45pm EST

  • Electrosurgical Leaflet Modification to Prevent Coronary Obstruction During Transcatheter Aortic Valve Replacement in Failing Native and Bioprosthetic Valves: The TELLTALE Trial – Presented by Dr Toby Rogers
  • Transcatheter Aortic Valve Replacement for Failing Bioprosthetic Surgical Valves: Five-Year Outcomes of the PARTNER 3 Aortic Valve-in-Valve Registry – Presented by Dr S Malaisrie
  • Outcomes in the ALIGN-AR Continued Access Study for the First Dedicated Transcatheter Aortic Valve for Aortic Regurgitation – Presented by Dr Raj Makkar
  • Outcomes of Single Antiplatelet, Dual Antiplatelet, or Oral Anticoagulation After Amulet: Insights From Emerge LAA Post-Approval Study – Presented by Dr Atman Shah

 

Late-Breaking Clinical Trials: Endovascular

Tuesday 11th March, 08:00  – 09:00am EST

  • Evaluation of Long-Term Key Outcomes and Safety in Pulmonary Embolism: The EKOS-PE Study – Presented by Dr Sameh Sayfo
  • Large-Bore Mechanical Thrombectomy for Intermediate-Risk Pulmonary Embolism in Patients With Contraindications to Thrombolytics: Outcomes From the Non-Randomized PEERLESS Cohort – Presented by Dr Stefan Stortecky
  • One-Year Outcomes of the Prospective, Multi-Center, Single-Arm Study of the 355-nm Laser for Treatment of Below-the-Knee Arteries: Final Results of the Auryon BTK – Presented by Dr Nicolas Shammas
  • US Pivotal Study of the Vivasure PerQseal System for Large Hole Closure: PATCH – Presented by Dr Zvonimir Krajcer

 

Late-Breaking Clinical Science: Coronary

Saturday 8th March, 15:15 – 16:30pm EST

  • Drug-Coated Balloons vs Drug-Eluting Stents for the Treatment of Large Native Coronary Artery Disease: A Meta-Analysis of Randomized Controlled Trials – Presented by Dr Jose Romero
  • Sirolimus-Coated Balloon vs Drug-Eluting Stent in Elderly Patients With Coronary Artery Disease: A Propensity-Score Matched Comparison – Presented by Dr Filippo Gurgoglione
  • Institutional Variability in Processes of Care and Outcomes Among Patients With ST-Elevation Myocardial Infarction in the United States: Contemporary Insights From the American Heart Association Get With The Guidelines® – Coronary Artery Disease (GWTG-CAD) Registry – Presented by Dr Yasser Sammour
  • Implementation of a Regional Extracorporeal Membrane Oxygenation Program for Out-of-Hospital Cardiac Arrest: Results of the Pilot Study – Presented by Dr David Shavelle

 

Late-Breaking Clinical Science: Structural I

Sunday 9th March, 14:15 – 15:30pm EST

  • Evaluating the Safety Profile of Transcatheter Tricuspid Valve Repair: Insights From the TRILUMINATE Pivotal Study of the TriClip System – Presented by Dr Paul Sorajja
  • Transcatheter Aortic Valve Replacement With Self-Expanding Valves vs Balloon-Expandable Valves – A Pooled Analysis From NAVULTRA and NEOPRO2 Registries – Presented by Dr Pier Leone
  • Evaluating Coronary Access After TAVR With the 4th and 5th-Generation Self-Expanding Valves – The EPROMPT-CA Study – Presented by Dr Lior Lupu
  • Supra-Annular vs Intra-Annular Devices for TAVR-in-TAVR: The Pandora International Registry – Presented by Dr Luca Testa

 

Late-Breaking Clinical Science: Structural II

Sunday 9th March, 16:30 – 17:20pm EST

  • Long-Term Hemodynamic Performance and Clinical Outcomes in Small and Large Aortic Annuli Patients With Severe Aortic Stenosis – Presented by Dr Yasser Sammour
  • Progression and Outcomes of Mild to Moderate Aortic Stenosis: Insights From the GUARD Prospective Observational Study – Presented by Dr Baravan Al-Kassou
  • Patent Foramen Ovale Closure in Patients With and Without Nickel Hypersensitivity: A Randomized Trial – Presented by Dr Anastasios Apostolos

 

Late-Breaking Clinical Science: Coronary II

Monday 10th March, 09:00 – 10:00am EST

  • FACT (Fentanyl and Crushed Ticagrelor) PCI: A Randomized Control Trial of Patients Undergoing Percutaneous Coronary Intervention Who Receive Ticagrelor and Fentanyl – Presented by Dr Asna Aafreen
  • Laser Excimer Compared to Very High-Pressure Dilatation to Treat Underexpanded Stents (Laser-Expand Trial) – Presented by Dr Neus Bellera
  • Comparison of Stent Geometry Achieved by Different Side-Branch Ballooning Techniques for Bifurcation Provisional Scenting: The Randomized CRABBIS Trial – Presented by Prof Francesco Burzotta
  • Patient Prosthesis Mismatch and Quality of Life: Data From a Large Multi-Center Registry – Presented by Dr Karim Al-Azizi

 

References

CRT 2025. Full Schedule. 2025. https://crt2025.eventscribe.net/agenda.asp?BCFO=M%7CP&pfp=BrowsebyDay&fa=&fb=&fc=&fd=&all=1 (accessed 5 February 2025).

Share: